| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |